Initial validation of a brief provisional diagnostic scale for delirium

Area of Science:

• Neuroscience
• Clinical Diagnostics
• Psychiatry

Background:

• Delirium is a common and serious complication following acquired brain injury (ABI).
• Accurate and timely diagnosis of delirium is crucial for effective management and improved patient outcomes.
• Existing diagnostic tools may have limitations in specific patient populations like those with ABI.

Purpose of the Study:

• To evaluate the accuracy and validity of the newly developed Delirium Diagnostic Tool-Provisional (DDT-Pro).
• To assess the DDT-Pro's performance in a population of patients with acquired brain injury (ABI).

Main Methods:

• A cross-sectional study design was employed.
• Thirty-six patients with ABI (traumatic brain injury and intraparenchymal hemorrhage) were assessed upon admission to inpatient rehabilitation.
• The DDT-Pro was administered alongside the Delirium Rating Scale-Revised 98 (DRS-R98) and DSM-IV-TR criteria.

Main Results:

• The DDT-Pro demonstrated high accuracy, with an Area Under the Curve (AUC) of 0.994 via receiver operating characteristic (ROC) analysis.
• The tool correctly classified 97% of observations against the DSM-IV-TR gold standard.
• Strong correlations were found between the DDT-Pro and the DRS-R98, both for raw scores (r = -0.913) and delirium duration (r = 0.975).

Conclusions:

• The Delirium Diagnostic Tool-Provisional (DDT-Pro) is a validated measure for detecting delirium in patients with acquired brain injury.
• Further validation studies in broader ABI and other medical populations are recommended to support its widespread clinical application.